DURECT Corporation to Present Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial and Report First Quarter 2019 Financial Results
DURECT Corporation (DRRX)
Last durect corporation earnings: 3/3 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
durect.com/investors
Company Research
Source: PR Newswire
CUPERTINO, Calif., May 3, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report preliminary data from the ongoing DUR-928 alcoholic hepatitis (AH) trial and its financial results for the three months ended March 31, 2019 after the market close on Tuesday, May 7. The following morning, Wednesday, May 8th at 8:30 a.m. Eastern Time, DURECT will host a Key Opinion Leader (KOL) and earnings conference call and webcast with slides. During the webcast and conference call, DURECT management will provide a corporate business update, including a presentation of preliminary data from the ongoing Phase 2a open label, dose escalation, multi-center U.S. clinical trial investigating DUR-928 administered intravenously in patients with moderate and severe AH. The objectives of this study include assessment of safety, PK and pharmacodynamic signals, including liver biochemistry and biomarkers.KOL Discussion on Alcoholic HepatitisAlso participating in the call will
Show less
Read more
Impact Snapshot
Event Time:
DRRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DRRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DRRX alerts
High impacting DURECT Corporation news events
Weekly update
A roundup of the hottest topics
DRRX
News
- DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- DURECT Co. (NASDAQ: DRRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $5.00 price target on the stock.MarketBeat
- DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.MarketBeat
- Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]Yahoo! Finance
DRRX
Earnings
- 3/27/24 - Beat
DRRX
Sec Filings
- 3/28/24 - Form 424B5
- 3/28/24 - Form 10-K
- 3/27/24 - Form 8-K
- DRRX's page on the SEC website